Enabling lung cancer screening with iBiopsy AI-based software as medical device

July 12, 2022 — Median Technologies (ALMDT) announced that the company will be participating in the 2022 European Congress of Radiology (ECR), to be held in Vienna, Austria, July 13-17. 

The company will give an industry presentation and a scientific paper presentation. Details of the sessions include:   

Industry presentation: “Enabling lung cancer screening with iBiopsy AI-based software as medical device”

 Session: AIX Theater 

 Date: July 13, 2022 

 Time: 3:25 pm – 3:45 pm CEST 

Scientific paper presentation:  RPS 1305-6 – “Development and validation of a machine learning based CADx designed to improve patient management in lung cancer screening programmes” 

Session: RPS 1305 - Artificial intelligence (AI) in chest imaging: part 2 

Categories: Artificial Intelligence & Machine Learning, Imaging Informatics, Chest, Oncologic Imaging 

Date: July 15, 2022  

Time: 10:30 am - 12:00 pm CEST 

Median’s team will be available at booth #AI-29, Expo X1, AI-area to discuss the presentations and present the latest developments on iBiopsy LCS CADe/CADx SaMD from July 13 to 17, 9:00 am-5:00 pm. 

The European Congress of Radiology (ECR) organized by the European Society of Radiology (ESR) is the premier European event in radiology and the second largest in the world. The congress conveys more than 20,000 with a split of more than 10,000 professional delegates (radiologists, technologists etc.), and ~8,000 industry participants (imaging modalities, PACS etc.). Radiology professionals from Europe and beyond attend to gather knowledge through educational courses, to see the latest innovations presented by technical exhibitors, and to discover groundbreaking research from scientific paper presentations.  

More about the ECR: https://www.myesr.org/congress   

For more information: www.mediantechnologies.com 

Find more ECR22 coverage here


Related Content

News | Magnetic Resonance Imaging (MRI)

September 28, 2023 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Magnetom ...

Time September 28, 2023
arrow
News | Point-of-Care Ultrasound (POCUS)

September 26, 2023 — Exo (pronounced “echo”), a medical imaging software and device company, today unveiled a category ...

Time September 26, 2023
arrow
News | Artificial Intelligence

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Time September 25, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Time September 21, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
News | Enterprise Imaging

September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM ...

Time September 20, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
Feature | Ultrasound Imaging | By Mustafa Hassan, PhD

Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million ...

Time September 20, 2023
arrow
News | Radiology Business

September 20, 2023 — GE HealthCare released its inaugural Sustainability Report, which describes the steps the company ...

Time September 20, 2023
arrow
Subscribe Now